Nephrocare Health Services Limited
NSE: NEPHROPLUSINE428V01029·Healthcare·www.nephroplus.com ↗·Mcap ₹7,473 Cr·Listed 2025
₹696.65▼ ₹12.85  (−1.81%)
52W: ₹446 – ₹782 · Vol: 5.9L shares · Close 25 Sept
Set Alert

News & Filings

NSE filings · newest first · 5 on record

Fri, 25 Sept, 2026

Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Trading windowTrading Window14:04 IST PDF 3.20 MB XBRL

Tue, 22 Sept, 2026

Schedule of meet
Investor meetAnalysts/Institutional Investor Meet/Con. Call Updates16:53 IST PDF 3.25 MB XBRL

Fri, 18 Sept, 2026

Credit Rating- Revision
Credit ratingCredit Rating- Revision20:56 IST PDF 3.41 MB XBRL
Other Restructuring - Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines as per the disclosure annexed herewith.
FilingOther Restructuring16:35 IST PDF 3.24 MB XBRL

Mon, 14 Sept, 2026

Nephrocare Health Services Limited has informed the Exchange about Agreements
M&A / agreementAgreements18:34 IST PDF 3.27 MB XBRL
Source: NSE corporate announcements, as filed by the company. Times are IST. Press coverage is not included yet.
Filing activity · 30 days
5filings · +5 vs the 30 days before
● Investor meets 1● Press & deals 1● Ratings 1● Regulatory 1● Other 1
NSE filings by type. Press coverage and sentiment are not included yet.
Material vs routine · 90 days
Material events 2 in 90 days
18 SeptCredit rating Credit Rating- Revision PDF
14 SeptM&A / agreement Nephrocare Health Services Limited has informed the Exchange about Agreements PDF
Routine disclosures 3
investor meets 1 · regulatory 1 · other 1
Split by NSE filing category: business events (results, ratings, deals, leadership, capital actions, regulatory) versus schedules, notices and general updates. Not a view on importance.
Corporate Actions
loading…